A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
PHASE2
This is a randomized, placebo-controlled, double blind phase 2 study design...
Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery
PHASE2
This randomized phase II trial studies how well tivantinib with or without ...
Status
Completed
Location
University of Arizona Cancer Center-Orange Grove Campus